Bachelor in Bio-Convergence

Tuition fees are 13,563,000 KRW per year.

Bio-Convergence at Yonsei University sits at the intersection of biology and engineering, focusing on how biological systems can be combined with technology to solve problems in medicine, industry, and research. Students typically study molecular biology, biochemistry, and physiology alongside engineering coursework in areas such as biomedical devices, bioinformatics, and biomaterials, learning to apply engineering methods to biological questions. Laboratory work is central to this field, giving students experience with the experimental and computational techniques used in biotechnology and biomedical research. Coursework often draws on multiple disciplines at once, reflecting how modern biological research increasingly depends on tools and approaches borrowed from engineering, computer science, and data analysis. Graduates pursue careers as biotechnology researchers, biomedical engineers, and laboratory scientists, working across pharmaceutical companies, medical device manufacturers, and research institutions. Many continue into graduate study, since advanced research roles in this field often require training beyond the undergraduate level, while others move into technical and regulatory roles within the biotechnology and healthcare industries. This bachelor's degree is offered by Yonsei University, located in the Seodaemun-gu district of Seoul, South Korea. The program runs for eight semesters, or four years, with intake in March or September. Instruction is delivered in English, allowing international students to study bio-convergence without needing to first learn Korean. By combining biological science with engineering methods, the program prepares graduates for interdisciplinary work in the growing biotechnology sector.